Litcius/Paper detail

Targeting the PI3K/mTOR pathway in idiopathic pulmonary fibrosis: Advances and therapeutic potential

Zhengyang Wang, Yanzhi Guo, Kaiyin Li, Yan Huo, Shuyan Wang, Suzhen Dong, Ming‐Liang Ma

2024Bioorganic & Medicinal Chemistry11 citationsDOI

Topics & Concepts

PI3K/AKT/mTOR pathwayChemistryIdiopathic pulmonary fibrosisDiscovery and development of mTOR inhibitorsPharmacologyCancer researchSignal transductionLungBiochemistryInternal medicineMedicineInterstitial Lung Diseases and Idiopathic Pulmonary FibrosisPI3K/AKT/mTOR signaling in cancerLung Cancer Treatments and Mutations
Targeting the PI3K/mTOR pathway in idiopathic pulmonary fibrosis: Advances and therapeutic potential | Litcius